Investors are positioning themselves ahead of November, according to Daniel Pearlstein, research analyst with Dundee Capital Markets.
The Canadian Federal Government’s Task Force on Marijuana Legalization and Regulation is expected to report back to the government in November before legislation is introduced in the spring of 2017. It is anticipated that the proposed changes will include both medical and recreational marijuana.

Analysts weigh in

Pearlstein said, “… I think a lot of investors are trying to get ahead of these catalysts that may imply supply and distribution for a recreational market, because the downside is even a two to three billion dollar market where you know the players are already in the race, they’re right here today.” He adds, “Even if recreational does not happen at all.”


 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Jason Zandberg of PI Financial shared the same sentiment on a note issued October 5, and says, “With the Canadian federal government expecting to introduce recreationally legal cannabis legislation next spring, those companies that are active in the medical MJ sector are poised to benefit.”

Canopy Growth hits a 52-week high

True enough, a number of cannabis stocks are trending upwards this week, and for good reason.
Canopy Growth (TSX:CGC) jumped to a record high of $5.80 at 10am on October 6, after announcing that its subsidiary, Tweed Inc., is releasing Leafs By Snoop, a line of marijuana products in partnership with rapper and “cannabis connoisseur” Snoop Dogg. Mark Zekulin, president of Tweed, said in the release. “We’re welcoming a cannabis culture icon into the Canadian industry.”
Canopy also has a Buy rating from PI Financial, with a 12-month target of C$5. In its recent research note, PI Financial says that “near term catalysts could light stock up.”

Some marijuana stocks registering gains this week

Vancouver-based Aurora Cannabis (TSXV:ACB) is up 12 percent, closing its second day of trading on the TSXV at $2.00 per share. Aurora Cannabis commenced trading on the TSXV on October 5, and operates a 55,200 square foot production facility in Mountain View County, Alberta, with plans to open a 600,000 square foot facility next year.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ontario-based Aphria Inc. (TSXV:APH) hit a high of $4.02 and ended the day at $3.32. The stock is up 160 percent year to date. Aphria touts itself as “the first public licenced medical cannabis producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”
OrganiGram Holdings (TSXV:OGI) hit a high of $2.42 earlier in the day, and closed at $2.02. The stock is up 115 percent year to date. Organigram’s production facility and R&D is located in Moncton, New Brunswick, with a current production capacity of 2,700 kg/yr.
Mettrum Health (TSXV:MT) hit $4.24 earlier on October 6, and closed at $3.66. The stock is up 93 percent year to date. Mettrum has three licensed facilities in Ontario with an annual production capacity of approximately 12,000 kilograms. Economist Michael Decter has listed Mettrum as a “Top Pick”.
Investors should certainly take note that analysts predict the positive rally to continue on until the Fed’s Task Force proposes changes to the current marijuana regulations. Continue to watch this space to see future developments.
 
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Pia Rivera, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Mettrum Health is a client of the Investing News Network. This article is not paid-for content.
 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less